Marks Group Wealth Management Inc raised its holdings in Danaher Co. (NYSE:DHR – Free Report) by 6.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,972 shares of the conglomerate’s stock after acquiring an additional 312 shares during the quarter. Marks Group Wealth Management Inc’s holdings in Danaher were worth $1,141,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. bought a new position in Danaher during the fourth quarter valued at about $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher in the fourth quarter worth about $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher during the 4th quarter worth about $31,000. Finally, Pineridge Advisors LLC increased its holdings in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares during the last quarter. 79.05% of the stock is owned by institutional investors.
Insider Buying and Selling at Danaher
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Report on Danaher
Danaher Trading Up 0.3 %
Shares of Danaher stock opened at $202.22 on Thursday. The company’s fifty day moving average price is $231.17 and its two-hundred day moving average price is $250.62. The firm has a market capitalization of $146.06 billion, a PE ratio of 38.30, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the firm earned $2.09 earnings per share. On average, analysts expect that Danaher Co. will post 7.67 EPS for the current year.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is 20.45%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What Are Trending Stocks? Trending Stocks Explained
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 Warren Buffett Stocks to Buy Now
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.